If you’re considering prescribing ADUHELM, the PATH program could help eligible patients access their medication.
The PATH program provides ADUHELM financial assistance* to eligible patients.
*Patient out-of-pocket cost may vary based on financial and other income considerations. This program only covers the cost of ADUHELM. Other services or fees associated with treatment are not included and patient may have out-of-pocket costs associated with the same. Other restrictions apply. Biogen reserves the right to modify or discontinue this program with respect to any patient, or in its entirety, at any time. New enrollment ends 9/1/2024; program ends 12/31/2024. Contact Biogen Support Services for Patients for full program details and Terms and Conditions.
Contact Biogen Support Services
for Patients at 1-833-425-9360
The Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) is a voluntary provider-enrolled patient registry that collects information on treatments for Alzheimer’s disease, including ADUHELM. Providers may obtain information about the registry at www.alz-net.org or contact email@example.com.